3 Diabetes Diabetes.a growing health crisis in Britain 869m per year 10% of NHS budget
4 Projections.. 5 million by 2025 Youngest patient?
6 T2DM Type 2 diabetes is a chronic metabolic condition characterised by insulin resistance (that is, the body's inability to effectively use insulin) insufficient pancreatic insulin production, resulting in high blood glucose levels (hyperglycaemia)
7 T2DM Type 2 diabetes is commonly associated with obesity, Physical inactivity, Raised blood pressure, Disturbed blood lipid levels A tendency to develop thrombosis, and therefore is recognised to have an increased cardiovascular risk
8 T2DM It is associated with long-term microvascular and macrovascular complications, together with reduced quality of life and life expectancy.
10 NICE 2015 Monitor blood pressure every 1 2 months, and intensify therapy if the person is already on antihypertensive drug treatment, until the blood pressure is consistently below 140/80 mmhg (below 130/80 mmhg if there is kidney, eye or cerebrovascular damage)
11 NICE 2015 Involve adults with type 2 diabetes in decisions about their individual HbA1c target. Encourage them to achieve the target and maintain it unless any resulting adverse effects (including hypoglycaemia), or their efforts to achieve their target, impair their quality of life. [new 2015] In adults with type 2 diabetes, if HbA1c levels are not adequately controlled by a single drug and rise to 58 mmol/mol (7.5%) or higher: reinforce advice about diet, lifestyle and adherence to drug treatment and support the person to aim for an HbA1c level of 53 mmol/mol (7.0%) and intensify drug treatment. [new 2015] Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless: the person is on insulin or there is evidence of hypoglycaemic episodes or the person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery orthe person is pregnant, or is planning to become pregnant.
21 % of Subjects n = 404 We Are NOT At Goal % 7% GOAL Survey 12.4% 7.8% 17.0% 25.8% 37.0% 37.2% >8% A1C >10% >9% >8% 7-8% <7% Only 7% of adults with diabetes in NHANES attained: A1C level <7% Blood pressure <130/80 mm Hg Total cholesterol <200 mg/dl Adults aged years with previously diagnosed diabetes who participated in the interview and examination components of the National Health Examination Survey (NHANES), Saydah SH et al. JAMA. 2004;291:
22 Many patients are still failing to meet their treatment targets UNCONTROLLED 35% of people nationally OVERWEIGHT 90% of adults with type 2 diabetes are not meeting their treatment target of an HbA 1c of 58 mmol/mol (7.5%) 1 with type 2 diabetes are overweight or obese 2 How does this compare to your local figures? 1. Diabetes UK (2015) State of the Nation: Challenges for 2015 and Beyond (England). Available at: State-of-the-nation-challenges-for-2015-and-beyond/ (accessed ) 2. Public Health England (2014) Adult obesity and type 2 diabetes. Available at: (accessed )
23 Renal Handling of Glucose (180 L/day) (900 mg/l)=162 g/day Glucose SGLT2 S1 90% S3 SGLT1 10% No Glucose
26 Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes Bernard Zinman, M.D., Christoph Wanner, M.D., John M. Lachin, Sc.D., David Fitchett, M.D., Erich Bluhmki, Ph.D., Stefan Hantel, Ph.D., Michaela Mattheus, Dipl. Biomath., Theresa Devins, Dr.P.H., Odd Erik Johansen, M.D., Ph.D., Hans J. Woerle, M.D., Uli C. Broedl, M.D., and Silvio E. Inzucchi, M.D., for the EMPA-REG OUTCOME Investigators
27 EMPA-REG CONCLUSIONS Patients with type 2 diabetes at high risk for cardiovascular events who received empagliflozin, as compared with placebo, had a lower rate of the primary composite cardiovascular outcome and of death from any cause when the study drug was added to standard care. (Funded by Boehringer Ingelheim and Eli Lilly; EMPA-REG OUTCOME ClinicalTrials.gov number, NCT )
28 Number of patients <6 <6 Number of patients Type 2 HbA 1c levels when initiating insulin therapy Average HbA 1c is 10.1% Average HbA 1c is 10.4% Basal Only Basal Bolus Patients with HbA 1c recorded:19533 Patients with HbA 1c recorded: ,000 4,500 4,000 3,500 3,000 2,500 2,000 1,500 1, ,400 1,200 1, Level of HbA 1c control Level of HbA 1c control Source: CSD Patient Data, MAT to May 2013
29 < <6 12+ Number of patients Number of patients Type 2 HbA 1c control levels in UK patients on insulin Average HbA 1c is 8.8% Average HbA 1c is 8.8% Basal Only 39% of patients have HbA 1c >9%: 44,166 Basal Bolus 39% of patients have HbA 1c >9%: 95,676 25,000 20,000 15,000 10,000 40,000 33,000 30,000 25,000 20,000 15,000 5,000 10,000 5, Level of HbA 1c control Level of HbA 1c control Source: CSD Patient Data, MAT to May 2013
30 Effects of Meals and Snacks Dietary fiber Targets of grams/day Can be difficult to achieve Improves postprandial numbers for some Soluble fiber can lower cholesterol numbers Increases satiety Alcohol Can cause hypoglycemia, especially when taken without carbohydrates Don t forget, it s a source of calories Moderate intake associated with improved heart health
31 Effects of Physical Activity on Glucose Immediate effects Metabolism During and several hours after exercise Delayed effects 4 12 hours after exercise Long-lasting effects Improves insulin sensitivity Implications for glucose monitoring
32 Hypoglycemia Treatment Options Frequent Decrease medication Usually sulfonylurea or insulin Special problems associated with SU Intermittent Due to too little food Adjust food Decrease insulin dose if on insulin Due to too much physical activity Add carbs for extra fuel Decrease insulin dose if on insulin
33 Hyperglycemia Treatment Options Reduce food portions and/or carbohydrates Add in aerobic physical activity Resistance exercise adds benefit also Increase medication effect Dosage, timing Add new medication
34 Listening to Your Patient Collect the information Thank them for bringing it in Ask what they think about their numbers Look for barriers to checking glucoses Ask if you could share some of your thoughts on their numbers Give a brief interpretation Using AHH, emphasize average glucose goal and A1C Decide, with the patient, about an approach to take Changing food, activity, medication Discuss follow-up
35 The Basics Just Say AHH A1C and average blood glucose On target? (Do they know their target?) Hypoglycemia (<4 mmol/dl) Fasting or postprandial? Frequent or intermittent? Symptoms? Hyperglycemia (>fasting/postprandial target) Fasting or postprandial? Frequent or intermittent?
36 Weight loss 13% wt loss 0.6gm from pancreas Reversal of diabetes
37 New Diagnosis and control "Prompted by the case of a newly diagnosed diabetic lady who experienced a deterioration of vision after rapid lowering of her blood sugar, in Cornwall we have reviewed the advice regarding management of diabetes in newly diagnosed type 2 diabetic people having significant hyperglycaemia and whose retinopathy status is unknown.
38 Case Through regular GP/Diabetes updates we have disseminated advice to our colleagues in primary care that newly diagnosed type 2 diabetics should be offered diabetic retinopathy screening as soon as possible, and importantly, not to initiate rapid improvement in glycaemic control until the retinopathy status is known to be mild (R1) Our screening service operates from some 70 sites throughout Cornwall and, in practice, we can usually offer a screening appointment within one week for such patients. Patients with sight threatening retinopathy (R2 or R3) are fast-tracked for further assessment and treatment in the hospital eye service and with careful liaison with Primary Care Practitioners and where appropriate our diabetologists regarding glycaemic management.
39 Case In general, our diabetologists recommend lowering of blood sugar 0.5% or 6 mmol/mol every six months and a combination of insulin and metformin is frequently advised to achieve predicted control. It should also be recognised that some medications, e.g. sulphonylureas and/or SGLT2 blockers should be avoided as they have the potential to lead to a poweful, sudden reduction of blood sugar with adverse effects on preexisting retinopathy."
Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk Silvio E Inzucchi, Christoph Wanner, John M Lachin, David Fitchett, Stefan Hantel, Michaela
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
i Diabetes Mellitus Toolkit Table of Contents Acknowledgments...ii Overview of Diabetes Mellitus Toolkit...1 Medical Nutrition Therapy Protocol Forms for Implementing Diabetes Mellitus Type 1 and 2 Evidence-based
Chapter 20 Diabetes Mellitus Chapter 20 Lesson 20.1 Key Concept Diabetes mellitus is a metabolic disorder of glucose metabolism with many causes and forms. About Diabetes 20.8 million Americans have diabetes
Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic
Type 2 Diabetes: When to Initiate And Intensify Insulin Therapy Julie Bate on behalf of: Dr John Wilson Endocrinologist Capital and Coast DHB Declarations I have received travel funding and speaker fees
Hypoglycemia in an Elderly T2DM Patient with Heart Failure 1 I would like to introduce you to Sophie, an elderly patient with long-standing type 2 diabetes, who has a history of heart failure, a common
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,
Guidelines on Self Monitoring of Blood Glucose (SMBG) Developed in conjunction with Cumbria Diabetes August 2014 0 Type 1 Diabetes Self Monitoring of Blood Glucose (SMBG) is an integral part of treatment
WHAT IS DIABETES MELLITUS? CAUSES AND CONSEQUENCES DEDBT01954 Lilly Deutschland GmbH Werner-Reimers-Straße 2-4 61352 Bad Homburg Living your life as normal as possible www.lilly-pharma.de www.lilly-diabetes.de
Nutrition Therapy in Diabetes Mellitus. Dorothy Debrah Diabetes Specialist Dietitian University Hospital, Llandough. Wales, UK February 2012 University Hospital Llandough DIABETES MELLITUS. Definition:
Diabetes in Primary Care course MCQ Answers 2016 Diagnosis of Diabetes HbA1C should not be used as a diagnostic tool in the following situations: (answer each TRUE or FALSE) 1. Gestational Diabetes TRUE
Weight loss in people with type 2 diabetes Prevalence of type 2 diabetes Currently, the estimated global prevalence of diabetes is over 285 million and this figure is expected to increase to 438 million
Introduction NICE Guidelines : Diabetes in Pregnancy 650,000 births in England & Wales per year 2 5% women have diabetes 87% diabetic pregnancies due to gestational diabetes Prevalence diabetes is increasing
Insulin-Treated Diabetes Guidelines for assessment of fitness to work as Cabin Crew General Considerations As with all medical guidelines it is important that each individual case is assessed on its own
Personalized Therapy Algorithms for Type 2 Diabetes: A Phenotypization-based Approach Riccardo Candido on behalf of the Personalized Therapy AMD Study Group Diabetes Canter A.S.S. 1 Triestina, Italy BACKGROUND
Type 2 Diabetes Type 2 diabetes is the most common form of diabetes, accounting for 90 95% of cases. 1 Charts 1 and 2 reflect the effect of increasing prevalence on prescribing and costs of products used
Diabetes in children and young people: diagnosis and management of type 1 and type 2 diabetes in children and young people Review questions Type 1 diabetes What is the effectiveness of C-peptide and antibody
KEY FACTS Diabetes is on the rise, and is among the top 10 causes of death in Singapore. Indians are most likely to have diabetes, followed by the Malays and Chinese. The risk of diabetes can be reduced
Therapeutic Inertia Dr Samuel Seidu. Declaration of interests Sam Seidu has acted as advisory board member and/or speaker for Novartis, Janssen, Novo Nordisk, Lilly, Boehringer Ingelheim, MSD, Amgen, Astra
Good Practice Guide on Rail Workers and Diabetes Good Practice Guide on Rail Workers and Diabetes General Guidance Synopsis: This document provides guidelines and advice for rail workers regarding diabetes.
Case study: Adult with uncontrolled type 2 diabetes of 3 years duration Authored by Pablo Aschner and Linong Ji on behalf of the Global Partnership for Effective Diabetes Management. The Global Partnership
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
A Guide to Monitoring Blood Glucose for Patients with diabetes in Care Homes 1. Summary... 1 2. Background... 2 3. Purpose 2 4. Responsibilities. 2 5. Blood Glucose Monitoring. 2 6. Resident Groups that
KENTUCKY DIABETES NETWORK, INC. Algorithms for Glycemic Management of Type 2 Diabetes The Diabetes Care Algorithms for Type 2 Diabetes included within this document are taken from the American Association
20 21 Two of my uncles struggled with diabetes, and neither was ever able to get it under good control. Ultimately, both of them passed away from the complications of diabetes. Likewise, my cousin is currently
Diabetes: improving control This short decision aid is to help you decide what treatment to choose if you have type 2 diabetes that is not well controlled. This document is a summary of the online patient
Type 1 Diabetes- An autoimmune disease in which the body does not produce any insulin, mostly occurring in children and young adults. People with type 1 diabetes must take daily insulin injections to stay
The MFP Transition Coordinator can use this information to determine what participant will be able to do and what additional supports may need to be put in place. Definition: Diabetes is a chronic disease
Group 1 notes Abi / Nicole Type 2 Diabetes workshop notes 4.1 Population The group discussed the following sub groups that may need addressing: Men-as they tend to die earlier compared with women, their
Diabetes Mellitus case studies Jana Vinklerová Definition of diabetes (metabolic disorder) Chronically raised blood glucose (hyperglycaemia) Insulin/Glucagon Insulin is responsible for lowering glucose
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Type 1 diabetes: diagnosis and management of type 1 diabetes in adults 1.1 Short title Type 1 diabetes in adults 2 The remit
TYPE 2 DIABETES MANAGEMENT OVERVIEW Diet and physical activity are critically important in the management of the ABCs (A1c, Blood pressure and Cholesterol) of type 2 diabetes. To effectively manage A1C
EMPA-REG OUTCOME Trial Backgrounder Introduction About 415 million people worldwide have diabetes a chronic condition that occurs when the body does not properly produce or use the hormone insulin. 1 In
Diabetes Care Diagnosis and onwards to end of life D R A S O L O M O N L I Z G R E G O R Y A N D S O N I A F U L L E R T O N S E P T 2 0 1 4 Aims of this session: To outline the current national perspective
Type 2 Diabetes Media Fact Sheet 1. Type 2 diabetes: Facts & figures 2. What is type 2 diabetes? 3. Risk factors for type 2 diabetes 4. Complications associated with type 2 diabetes 5. The socio-economic
Focus on CME at the University of Alberta Tips for Type 2: Treating Diabetes Mellitus Edmond A. Ryan, MD, FRCPI, FRCPC How should I approach Type 2 diabetes? The approach to Type 2 diabetes encompasses
Inpatient Treatment of Diabetes Alan J. Conrad, MD Medical Director Diabetes Services EVP, Physician Alignment Diabetes Symposium November 12, 2015 Objectives Explain Palomar Health goals for inpatient
Diabetes Care Improvement Packages. Role of Primary Care Dr Jeremy Krebs Clinical Leader and Endocrinologist Wellington Hospital Diabetes Mellitus How big is the problem? Diabetes Care Improvement Packages
List of questions I. General concepts and diagnostic tests Diabetes mellitus 2 Glycosylated haemoglobin (HbA1c) 6 Self-monitoring of blood sugar levels 7 How to take an insulin shot 9 Travel tips 10 1.
Perioperative Management of Diabetes S Rajbhandari (Nepal/UK) Diabetes in Nepal 19.0% above the age of 40 have diabetes in urban area Shrestha Diabet Med 23 (2006)1130 25.9% above the age of 60 have diabetes
Diabetes Self Management Clinical Data Record Book Please take this book with you to all Health Related Visits This Book Belongs to: Name: Address: Phone: In Case of Emergency Please Contact: Name: Relationship:
Network Rail Diabetes Management Guidance for Line Managers November 2007 Department Owner Safety and Compliance Content Manager Valmai Hughes, Occupational Health Specialist Version 1.0 Date issued November
Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL SCHOOL DOCTORATE THESIS - Summary CHRONIC COMPLICATIONS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS - Epidemiological study - PhD Manager: Professor PhD.
Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Greg Doelle MD, MS April 6, 2016 Disclosure I have no actual or potential conflicts of interest in relation to the content of this lecture.
Diabetes and ramadan K. Abdallah (Egypt) Diabetes and Ramadan Khalifa Abdallah Professor of Internal Medicine Unit of Diabetes & Metabolic Diseases Alexandria Faculty of Medicine Istanbul 9 MAY 2015 Disclosure
Rationale for ADA Treatment Guidelines for CVD Prevention Robert E. Ratner, MD American Diabetes Association 1 No Financial Disclosures 2 Trends in age-standardized rates of diabetes-related complications
Chapter 27 Pregnancy and Diabetes Satish Garg, MD H. Peter Chase, MD INTRODUCTION This book has been used primarily by families of children with diabetes. Because of the increased readership recently by
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus NICE has developed the Cochrane Quality and Productivity (QP) topics to help the NHS identify practices
Diabetes Aim To have understanding of diabetes Define diabetes Objectives Identify normal and abnormal blood glucose ranges Outline the risk factors associated with diabtes Identify the importance of documentation
Guide to antenatal diabetes care and antenatal diabetes clinics in Lothian for specialist registrars This is an introduction to and summary of recommendations for antenatal diabetes care, with particular
www.leicestershirediabetes.org.uk Diabetes Care UHL Newly Diagnosed Type 2 Diabetes What Happens Next? A guide for patients and healthcare professionals Introduction The Diabetes Team have produced this
CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing
EMA/188850/2014 Summary of the risk management plan (RMP) for Jardiance (empagliflozin) This is a summary of the risk management plan (RMP) for Jardiance, which details the measures to be taken in order
Algorithms for Glycemic Management of Type 2 Diabetes KENTUCKY DIABETES NETWORK, INC. The Diabetes Care Algorithms for Type 2 Diabetes included within this document are taken from the American Association
Managing diabetes in the post-guideline world Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ) Overview Pathogenesis of T2DM Aims of treatment The place of glycaemic control Strategies to improve glycaemic
Insulin Pump Therapy for Type 1 Diabetes Aim(s) and objective(s) This guideline has been developed to describe which patients with Type 1 Diabetes should be referred for assessment for insulin pump therapy
Slide 1 General Information for Serving Students with Diabetes Child Nutrition Programs Oregon Department of Education Hi. This is Janet Beer for the Child Nutrition Programs at the Oregon Department of
Glucose Tolerance Testing PROTOCOLS FOR PERFORMING GLUCOSE TOLERANCE TESTS INTRODUCTION Described in this section are the sample requirements, patient preparation instructions, dosages of substances to
Cancer treatment and diabetes Dr Daniel Morganstein Consultant Endocrinologist, 1 2 Diabetes and cancer Cancer and its treatment also poses challenges to managing diabetes Surgery Altered appetite Cachexia
PCT Prescribing Report Drugs used in Type 2 Diabetes Discussion Points 1. Does your PCT have a strategy for prevention of type 2 diabetes? Does your PCT provide the sort of intensive multifactorial lifestyle
2. What Should Advocates Know About Diabetes? O ften a school district s failure to properly address the needs of a student with diabetes is due not to bad faith, but to ignorance or a lack of accurate
Reconciling Current Diabetes Guidelines Jaime A. Davidson, MD, FACP. FACE Part 1. Diagnosis Welcome. I am Dr. Jaime Davidson, a clinical professor of medicine in the Department of Internal Medicine, Division
1 Nutrition Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 2 Type 2 Diabetes: A Growing Challenge in the Healthcare Setting Introduction and background of type 2 diabetes:
Christian In better control with his pump since 2012 WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES? Many people with Type 1 diabetes worry about potential long-term
Information for the public Published: 26 August 2015 nice.org.uk About this information NICE guidelines provide advice on the care and support that should be offered to people who use health and care services.
Sample GP Report For r Information Laboratory Testing in Diabetes Report bpac nz better medicine Sample GP Report Laboratory testing in the monitoring of people with diabetes The complications of diabetes
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
CLINICAL AUDIT Stepping up treatment in people with poorly controlled diabetes Valid to December 2018 bpac nz better medicin e Background Type 2 diabetes is a progressive disease characterised by insulin
The basal plus strategy Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE ADA/EASD guidelines recommend use of basal insulin as early as the second step
EMA/467911/2014 Summary of the risk management plan (RMP) for Xultophy (insulin degludec / liraglutide) This is a summary of the risk management plan (RMP) for Xultophy, which details the measures to be
linagliptin, 5mg film-coated tablet (Trajenta ) SMC No. (746/11) Boehringer Ingelheim / Eli Lilly and Company Ltd 09 December 2011 The Scottish Medicines Consortium (SMC) has completed its assessment of
Introduction Diabetes is a chronic disease that affects the body s ability to metabolize food. The body converts much of the food we eat into glucose, the body s main source of energy. Glucose is carried